scispace - formally typeset
R

Ronald L. Menlove

Researcher at University of Utah

Publications -  73
Citations -  7761

Ronald L. Menlove is an academic researcher from University of Utah. The author has contributed to research in topics: Transplantation & Streptokinase. The author has an hindex of 30, co-authored 73 publications receiving 7610 citations. Previous affiliations of Ronald L. Menlove include United States Department of Veterans Affairs & LDS Hospital.

Papers
More filters
Journal ArticleDOI

The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.

TL;DR: Monitoring the timing of antibiotic prophylaxis and the occurrence of surgical-wound infections in 2847 patients undergoing elective clean or "clean—contaminated" surgical procedures at a large community hospital found that 10 patients who received the proPHylactic antibiotics preoperatively subsequently had surgical-Wound infections.
Journal ArticleDOI

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

TL;DR: It is concluded that failing human ventricular myocardium contains a relatively high proportion of beta 2 receptors, due to selective down-regulation of beta 1 receptors, and is available for inotropic stimulation by selective beta 2 agonists.
Journal ArticleDOI

The Timing of Prophylactic Administration of Antibiotics and the Risk of Surgical-Wound Infection

TL;DR: In surgical practice there is considerable variation in the timing of prophylactic administration of antibiotics and that administration in the two hours before surgery reduces the risk of wound infection.
Journal Article

Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.

TL;DR: It is concluded that immunofluorescence should be routinely done on all heart biopsies for the first month after transplantation, because patients with vascular (humoral) rejection cannot be reliably identified by any other means.